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Abstract: The human fungal pathogen Candida albicans is a dimorphic opportunistic pathogen that
colonises most of the human population without creating any harm. However, this fungus can also
cause life-threatening infections in immunocompromised individuals. The ability to successfully
colonise different host niches is critical for establishing infections and pathogenesis. C. albicans can
live and divide in various morphological forms critical for its survival in the host. Indeed, C. albicans
can grow as both yeast and hyphae and can form biofilms containing hyphae. The transcriptional
regulatory network governing the switching between these different forms is complex but well
understood. In contrast, non-DNA based epigenetic modulation is emerging as a crucial but still
poorly studied regulatory mechanism of morphological transition. This review explores our current
understanding of chromatin-mediated epigenetic regulation of the yeast to hyphae switch and biofilm
formation. We highlight how modification of chromatin structure and non-coding RNAs contribute
to these morphological transitions.
Keywords: Candida albicans; epigenetic; yeast; chromatin; biofilm; hyphae
1. Introduction
Epigenetics is a popular term first defined by Conrad Waddington in the early 1940s
as "the process by which the genotype brings the phenotype into being" [1]. Since then,
the meaning of epigenetics has significantly changed. Arthur Riggs defined epigenet-
ics as the study of mitotically and/or meiotically heritable changes in the gene function
that are not explained by changes in the DNA sequence [2]. Riggs’ definition focuses
on heritability: the ability of an epigenetic mark to be passed to subsequent generations
of cells and/or organisms. There is no doubt that heritable epigenetics is an important
regulatory mechanism. However, this definition excludes many important, not heritable
mechanisms often labelled as "epigenetic". For example, post-translation modifications of
histone proteins and their effect on gene expression are often described as an epigenetic
regulatory mechanism. However, chromatin marks are, in the majority of the cases, tran-
sient and not heritable. Likewise, Riggs’ definition excludes the role of non-coding RNAs
(ncRNAs) in transcription and other DNA-based organisms. To overcome this conundrum,
Adrian Bird redefined epigenetics as "the structural adaptation of chromosomal regions to
register, signal or perpetuate altered activity states" [3]. This definition focuses on changes
in gene function that are independent of changes in the underlying DNA sequence. Impor-
tantly, these changes can be heritable or not. Epigenetic regulatory mechanisms include
changes in gene expression and chromosome function triggered by chromatin modification,
chromatin remodelling and ncRNAs activity [2–8]. In this review, we will adopt Adrian
Bird’s definition.
Human fungal pathogens are microbial organisms that kill more than 1.5 million
people annually and reduce the quality of life of >1 billion people [9]. Additionally, the
recent staggering escalation in the number of invasive fungal infections and the emergence
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of antifungal drug resistance poses an ever-increasing threat to human health. Fungal
pathogens grow in association with their host, and establishing how these organisms
adapt to hostile host environments is key to understanding how they cause life-threatening
infections and develop resistance to antifungal drugs.
Chief among human fungal pathogens is Candida albicans, a CTG(Ser1)-clade organism
in which the CTG codon is translated as serine rather than leucine [10,11]. C. albicans
colonises almost every organ in the human body, and therefore, it is exposed to rapid
environmental changes [12]. Indeed, C. albicans is a harmless commensal yeast found in
the skin, gut, oral cavity and mucosa [13]. However, this fungal pathogen can become
virulent, establishing an extensive range of mucosal and systemic infections. For example,
C. albicans can cause vulvovaginal candidiasis (VVC), an infection estimated to afflict 75%
of all women at least once in their lifetime [14] or candidiasis, systemic infections that
can be life-threatening in immunocompromised individuals and are associated with high
mortality rates (up to 50%) [9]. Phenotypic plasticity is a critical regulatory mechanism
that drives rapid adaptation to hostile host environments. Indeed, environmental changes
can induce dramatic morphological changes, and phenotypic switches are critical host
adaptation and virulence drivers. For example, C. albicans can grow as a single rounded
yeast cell or as multicellular hyphae. Yeast cells are critical for host colonisation, early
infection and dissemination, while hyphae facilitate tissue invasion and damage [15,16].
Filamentous cells are also crucial for biofilm formation, a highly organised structure that
confers resistance to antimicrobial therapies and the host immune response [17]. C. albicans
cells can also switch between a white and opaque state. White and opaque cells have
different appearances, gene expression profiles and mating behaviours [18].
Epigenetic regulatory mechanisms are emerging as essential modulators of C. albicans’
phenotypic plasticity. Indeed, epigenetic regulation can sense environmental changes
leading to the rapid and reversible modulation of gene expression and adaptation to hostile
environments. Recently, Qasim et al. [19] reviewed the role of epigenetics in the white–
opaque switch extensively. This review will discuss the contribution of epigenetics to
C. albicans phenotypic plasticity by focusing on the gene-regulation changes in the yeast
-hyphae switch and biofilm formation.
2. C. albicans’ Chromatin Structure: The Basics
In eukaryotes, DNA is packed around specific histone proteins within the nucleus to
form a compact structure called chromatin. The basic unit of chromatin is the nucleosome,
formed by 147 base pairs (bp) of DNA wrapped around an octamer of histones. This
octamer is composed of two dimers of the histones H2A–H2B and the histone tetramer
(H3)2(H4)2. Nucleosomes are organised into arrays that are further packaged by histone
H1, promoting chromatin folding into compact fibres [20] (Figure 1). The diploid C. albicans
genome contains two homologous pairs of divergently transcribed histones H2A (HTA1
(orf19.6924)) and H2B (HTB1 (orf19.6925)), as well as histone H3 (HHT2 (orf19.1853) and
HHT21 (orf19.1061)) and H4 (HHF1 (orf19.1059) and HHF2 (orf19.1854)) genes. A putative
histone H1 (HHO1 (orf19.5137.1)) can also be identified [21]. Although histones are slow-
evolving proteins, variability in histone proteins has been documented in most eukaryotes
and histone variants play critical biological roles [22–24]. For example, the histone H3
variant, CENP-ACse4, epigenetically defines centromeres in each chromosome. C. albicans
CENP-ACse4 marks regional centromeres associated with its eight chromosomes [25].
Chromatin allows the packaging of DNA into a compact structure that can fit inside
the nucleus while permitting efficient accessibility to DNA-binding proteins. However,
chromatin is also an obstacle to all DNA-templated biological processes, including tran-
scription, replication, recombination and repair [26]. Consequently, changes in chromatin
structure can have a profound impact on nuclear processes, and chromatin is a crucial
regulator of DNA-based activities. For example, chromatin can be assembled into two
functionally and structurally different chromatin structures. Gene-rich regions and non-
repetitive DNA are assembled into euchromatin, an open chromatin state that is permissive
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to transcription. In contrast, heterochromatin is a transcriptionally silent chromatin state
that is associated with gene-poor and repetitive regions of the genome [27]. Chromatin
structure can be modulated by three distinct mechanisms: (i) post-translation modification
of histone proteins, (ii) chromatin remodelling and (iii) ncRNAs (Figure 2).
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Figure 1. Chromatin organisation and compaction in eukaryotes. Chromatin, a DNA–protein complex, forms chromo-
somes within the nucleus of eukaryotic cells. The central unit of chromatin is the nucleosome composed of a histone oc-
tamer and DNA. Histone H1 promotes further chromatin folding in some eukaryotes. 
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Figure 2. Mechanisms of modulation in chromatin structures. (A) Left: schematics of chromatin writers and erasers: writ-
ers, such as HATs and HMTs, add epigenetic marks to histone proteins, while erasers, such as HDACs and HDMs, remove 
epigenetic marks from histone proteins. Right: schematic of how post-translation modifications, such as histone acetyla-
tion, can affect DNA-histone interactions. (B) Modes of action of readers and chromatin remodelers. Left: reader proteins, 
components of chromatin remodelling complex, bind modified histone tails recruiting or blocking transcription factors. 
Right: schematics of chromatin remodellers' activity, including histone eviction and nucleosome sliding. (C) Mode of ac-
tion of non-coding RNAs (ncRNAs). Top: ncRNAs can recruit modifiers to chromatin or act as a scaffold promoting the 
formation of protein complexes. Middle: ncRNAs can activate or repress transcription. ncRNAs can also be processed into 
siRNAs by the RNAi machinery. siRNAs can seed heterochromatin formation. HAT: histone acetyltransferase; HMT: his-
tone methyltransferase; HDAC: histone deacetylase; HDM: histone demethylase; RSC: remodels the structure of chroma-
tin. 
3. Histone Post-Translational Modifications 
Histone proteins are formed by a globular core and unstructured basic amino-termi-
nal tails that can be post-translationally modified. The most common post-translational 
modifications (PTMs), also known as histone marks, include methylation, acetylation, 
ubiquitination, ADP-ribosylation and the sumoylation of lysine (K) residues; the methyl-
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3. Histone Post-Translational Modifications
Histone proteins are formed by a globular core and unstructured basic amino-terminal
tails that can be post-translationally modified. The most common post-translational modi-
fications (PTMs), also known as histone marks, include methylation, acetylation, ubiquiti-
nation, ADP-ribosylation and the sumoylation of lysine (K) residues; the methylation of
arginine (R) residues and the phosphorylation of serine (S) and threonine (T) residues. In
addition, the same amino acid can be affected by multiple modifications (i.e., mono, di- or
tri-methylated) [28].
Histone marks are differentially associated with euchromatin a d heterochromatin
regions. At euchromatic transcriptionally active regions, genes promoters are assembled
into a chromatin state containing acetylated histones that are tri-methylated on H3K4
(H3K4me3), while histone H3 methylated on K36 (H3K36me) is found at gene bodies [26].
Likewise, enhancers and super-enhancers are marked by the mono-methylation of histone
H3 on K4 (H3K4me1) and the acetylation of histone H3 on K27 (H3K27Ac) [29,30]. Genome-
wide chromatin profiling demonstrates that the C. albicans transcriptionally active genome
is packaged into canonical euchromatin, where gene promoters of active genes are enriched
in H3K4me3 while gene bodies are marked byacetylated histone H3 (H3K9Ac) and H4
(H4K16Ac) (Figure 3) [31]. In many eukaryotic organisms heterochromatic regions are en-
riched in repressive histone marks, such as the methylation of K9 on histone H3 (H3K9me)
or the methylation of K27 on histone H3 (H3K27me). Furthermore, high levels of DNA
methylation on position five of cytosines (5mC) are associated with heterochromatin [26,32].
Similarly to S. cerevisiae, C. albicans is devoid of H3K9me and H3K27me [33]. Although 5mC
mark has been detected in C. albicans, it is unclear whether DNA methylation is associated
Pathogens 2021, 10, 1463 5 of 16
with heterochromatic regions in this organism [34]. Instead, chromatin profiling studies
have demonstrated that C. albicans heterochromatic regions are characterised by low levels
of both histone acetylation and methylation [31] (Figure 3).
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The post-translation modification of histone proteins is a dynamic and reversible
process catalysed by "writer" and "eraser" enzymes that add and remove epigenetic marks
(Figure 2). For example, the additions of acetyl groups to histone tails are carried out
by histone acetyltransferases (HATs), whereas their removal is conducted by histone
deacetylases (HDACs); methylation marks are added by histone methyltransferases (HMTs)
and removed by histone demethylases (HDMs). Additionally, HAT and HDAC can also
catalyse the addition and removal of acyl groups different from those in acetylation, such
as crotonyl, succinyl, β-hydroxybutyryl, and propionyl [35]. The primary histone modifiers
found in C. albicans and their orthologs found in S. cerevisiae, S. pombe and humans are
listed in Table 1.
Table 1. Candida albicans histone modifiers and RNA interference actors and their orthologs in S. cerevisiae, S. pombe
and humans.
C. albicans Gene and
Known Function
Candida Genome [21]
S. cerevisiae Ortholog
SGD [36]
S. pombe Ortholog
Pombase [37]
Human Ortholog Alliance
of Genome Resources [38]
ESA1 (orf19.5416)
NuA4 HAT complex
acts on H4K5, H4K12
ESA1 (YOR244W)
(alias: TAS1, KAT5) MST1 (SPAC637.12c)
TIP60
(alias: KAT5)SAS2 (orf19.2087)
SAS HAT complex
acts on H4K16
SAS2 (YMR127C)
(alias: KAT8) MST2 (SPAC17G8.13c)
GCN5 (YGR252W)
(alias: ADA4, SW19,
AAS104, KAT2)
GCN5 (SPAC1952.05)
KAT2B
(alias: CAF)GCN5 (orf19.705)
SAGA/ADA complex KAT2A
(alias: GCN5)
ADA2 (YDR448W)
(alias: SWI8)
ADA2
(SPCC24B10.08c)
TADA2B
(alias: ADA2B)ADA2 (orf19.2331)
SAGA/ADA complex
acts on H3K9
TADA2A
(alias: ADA2A)
RTT109 (orf19.7491)
acts on H3K56
RTT109 (YLL002W)
(alias: KIM2, REM50,
KAT11)
rtt109 (SPBC342.06c) No ortholog
YNG2 (YHR090C)
(alias: EAF4, NBN1)
png1 (SPAC3G9.08)
ING3
(alias: Eaf4, ING2)
ING2 ±
(alias: ING1L)
ING4 ±
Histone
Acetyltransferase
YNG2 (orf19.878)
(alias: NBN1)
NuA4 HAT complex
acts on nucleosomal H4
ING5 ±
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Table 1. Cont.
C. albicans Gene and
Known Function
Candida Genome [21]
S. cerevisiae Ortholog
SGD [36]
S. pombe Ortholog
Pombase [37]
Human Ortholog Alliance
of Genome Resources [38]
NAT4 (orf19.4664) NAT4 (YMR069W) naa40(SPCC825.04c)
NAA40
(alias: NAT11, PATT1)
HAT1 (orf19.779) HAT1 (YPL001W)(alias: KAT1) hat1 (SPAC139.06)
HAT1
(alias: KAT1)
SAS3 (YBL052C)
(alias: KAT6) MST2 (SPAC17G8.13c)
KAT7
(alias: HBO1, MYST-2)
KAT6A ±
(alias: MYST-3)
KAT6B ±
(alias: MYST-4)
SAS3 (orf19.2540)
KAT8 ±
(alias: MYST-1)
HDA1 (YNL021W) clr3(SPBC800.03)
HDAC10
(alias: HD10)HDA1 (orf19.2606)
in a complex with Hda2 and
Hda3
HDAC6
(alias: HD6)
SET3 (YKR029C)
set3 (SPAC22E12.11c)
KMT2E *SET3 (orf19.7221)
SET3 HDAC complex with
Hos2, Snt1 and Sif2
SET4 (YJL105W)
(SET3 paralog) SETD5 *
RPD3 (orf19.2834)
RPD3
(YNL330C)
clr6
(SPBC36.05c)
HDAC1
(alias: KDAC1, RPD3)
RPD31 (orf19.6801) HDAC2(alias: KDAC2, RPD3)
HST1 (YOL068C)
(SIR2 paralog)
sir2 (SPBC16D10.07c) SIRT1 (alias: SIR2)
SIR2 (orf19.1992)
(alias: SIR21) SIR2 (YDL042C)
HST1 (YOL068C)HST1 (orf19.4761)
(alias: SIR22) SIR2 (YDL042C)
HST2 (YPL015C)
hst2
(SPCC132.02)
SIRT3HST2 (orf19.2580) SIRT2
Histone Deacetylase
HST3 (orf19.1934)
Acts on H3K56 HST3 (YOR025W)
hst4
(SPAC1783.04c) No ortholog
SET1 (YHR119W)
(alias: KMT2)
set1
(SPCC306.04c)
SETD1B
(alias: KMT2G)Histone
Methyltransferase
SET1 (orf19.6009)
Acts on H3K4 SETD1A
(alias: KMT2F)
RPH1 (YER169W) jmj3(SPBC83.07)
KDM4A
KDM4B
KDM4C
KDM4D
Histone
Demethylase RPH1 (orf19.2743)
KDM4E
SWR1 (orf19.1871)
SWR1 complex SWR1 (YDR334W) swr1 (SPAC11E3.01c)
SRCAP
(alias: SWR1)
SWI1 (YPL016W)
(alias: ADR6)
sol1 (SPBC30B4.04c)
ARID5A
(alias: MRF1)SWI1 (orf19.5657)
SWI/SNF complex ARID5B
(alias: MRF2)
SNF2 (YOR290C)
snf21
(SPAC1250.01)
SMARCA2SNF2 (orf19.1526)
SWI/SNF complex SMARCA4
STH1 (YIL126W) SMARCA2
Chromatin
Remodeler
STH1 (orf19.239)
RSC complex SMARCA4
DCR1 (orf19.3796) No ortholog dcr1 (SPCC188.13c) DICER1
No ortholog ago1 (SPCC736.11)
PIWIL1
PIWIL2
PIWIL3
RNA interference AGO1 (orf19.2903)
RISC complex
PIWIL4
(*) human orthologs are histone methyltransferase; (±) S. pombe ortholog only.
Histone marks alter chromatin architecture and its function via two main distinct
mechanisms. Firstly, PMTs can alter histone-DNA interaction modulating higher-order
chromatin structure and affecting gene expression and regulation [39]. For example, histone
acetylation reduces the net positive charge of histone tails, and therefore, will weaken
histone–DNA interaction, resulting in an open chromatin conformation that is permissive to
transcription (Figure 2A) [39]. Histone crotonylation activates transcription more potently
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than histone acetylation [40]. This is because the crotonyl group is more hydrophobic
and rigid than acetyl groups, disrupting histone-DNA interactions [40]. Histone marks
can also be recognised by "reader" proteins, which can influence chromatin dynamics
and function via promoting or blocking the recruitment of transcription factors and/or
other chromatin-modifying factors (Figure 2B) [41]. For example, bromodomain-containing
proteins specifically bind acetylated histones, chromodomain containing proteins recognise
specific methylation marks and the YEATS domain recognises the crotonyl marks [42].
4. Chromatin Remodelling Regulates Gene Expression and Chromatin Structure
Nucleosomes deposited on DNA can be a physical barrier, reducing chromatin ac-
cessibility and gene expression. Chromatin remodelling is the regulatory process that
changes the interactions between DNA and histone proteins leading to complete or partial
disassembly of the nucleosomes (histone eviction) or nucleosome reposition (nucleosome
sliding) [43] (Figure 2C). Chromatin remodelling is catalysed by ATP-dependent multi-
subunit protein complexes known as chromatin remodelers [43]. ATP-dependent chromatin
remodelers belong to four subfamilies: switch/sucrose non-fermentable (SWI/SNF), im-
itation switch (ISWI), chromodomain helicase DNA-binding (CHD/NuRD/Mi-2) and
inositol-requiring 80 (INO80) [44]. Among those, the SWI/SNF subfamily is the primary
remodeler catalysing nucleosome sliding and eviction. Initially identified in budding yeast,
SWI/SNF complexes are highly conserved across eukaryotes [45]. The SWI/SNF complex
can be targeted to acetylated transcriptionally active chromatin, as it can bind acetylated
histones (and non-histone proteins) through a bromodomain subunit [44]. Therefore,
SWI/SNF activity generally correlates with transcriptional activation even if the complex
has also been linked to transcriptional repression [46–50].
Different yeast species contain a second remodelling complex similar to SWI/SNF,
the RSC (remodels the structure of chromatin) complex [44]. This complex is essential for
survival in S. cerevisiae, although it is not required for growth in S. pombe [51]. The RSC
complex binds promoters and intergenic regions and is specifically recruited to RNA poly-
merase II to tune gene transcription [52]. Four chromatin remodeler catalytic subunits have
been described in C. albicans: STH1, SNF2, SWR1 and SWI1. Sth1 is the catalytic subunit of
the RSC complex, which in C. albicans is composed of a total of 13 subunits, including two
CTG (Ser1)-clade-specific (Nri1 and Nri2) [53]. Snf2 and Swi1 are catalytic subunits of the
SWI/SNF complex [54], and Swr1 is the major subunit of the SWR1 complex [55].
5. Non-Coding Transcription and Non-Coding RNAs
Large fractions of eukaryotic genomes are extensively transcribed but not translated
into functional proteins. The act of non-coding transcription and its associated histone
modifications and changes in nucleosome density can interfere with the activity of nearby
genes [56]. However, ncRNAs can also regulate gene expression by interacting with DNA,
RNA and proteins and modulating chromatin structure [57]. Finally, ncRNAs can be
processed into small silencing RNAs by RNA interference (RNAi) machinery. The RNAse
III-like enzyme dicer (Dcr) and the PIWI domain-containing protein Argonaute (Ago) are
at the core of the RNAi machinery and responsible for the generation of the three major
branches of small ncRNAs—short interference RNAs (siRNA), micro RNAs (miRNAs) and
PIWI-interacting RNAs (piRNAs)—that differ in their biogenesis and mechanisms of action
(Figure 4).
In the siRNA pathway, RNAi is triggered by a dsRNA precursor that can arise endoge-
nously by transcription of repetitive DNA and by convergent transcription. This precursor
dsRNA is processed into a 20–24-nucleotide (nt) siRNA duplex by Dcr [58]. One strand of
the duplex is loaded into Ago, an effector complex. Ago uses base-pairing interaction to
target cognate RNAs for inactivation. siRNA-mediated silencing can be co-transcriptional
by seeding the assembly of repressive heterochromatin or post-transcriptional RNA cleav-
age using Ago-slicer endonuclease activity. siRNA-directed heterochromatin assembly has
been best described in the fission yeast S. pombe, wherein RNAi machinery triggers the
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formation of transcriptionally silenced hypoacetylated chromatin, methylated on lysine
9 of histone H3 (H3K9) [59]. In the miRNA pathway, short stem-loop dsRNA precursors
are pre-processed by a nuclear RNAse III complex (Drosha–Pasha) before final process-
ing into miRNAs in the cytoplasm by Dcr. miRNAs are loaded into an Ago-containing
protein complex and targeted to the 3′ untranslated region (3′-UTR) of the target mRNA
blocking its translation [60]. The piRNA pathway silences transposable elements in the
germline of many animal species [61]. In contrast to the other pathways, piRNAs are not
generated by dsRNAs precursors and their biogenesis is independent of Dcr [62]. A single
transcript is generated from a piRNA cluster and processed into piRNAs by PIWI-domain
containing proteins. The piRNA pathway controls transposons through several distinct
but interlinked mechanisms. Whereas cytoplasmic PIWI proteins silence their targets
post-transcriptionally through piRNA direct cleavage, nuclear Piwi–piRNA complexes
function at the transcriptional level via heterochromatin assembly [63]. Although we still
know very little about the nature and the putative function of C. albicans non-coding RNAs,
RNA profiling analyses have identified many non-coding transcripts whose expression
differ under distinct growth conditions [64].
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Figure 4. RNA interference pathways. In the siRNA pathway, a precursor dsRNA is processed
into a siRNA duplex by dicer (Dcr), and one strand of the duplex is loaded into argonaute (Ago1),
which targets it against complementary RNAs for inactivation. In the miRNA pathway, loop dsRNA
precursors are processed, first, in the nucleus by drosha–pasha and later in the cytoplasm by dicer
to produce miRNAs. These are loaded into an Ago and targeted to the 3′-UTR region of the target
mRNA to block translation. In the piRNA pathway, a single transcript is generated from a piRNA
cluster and processed into piRNAs by PIWI-domain-containing proteins that silence their targets
post-transcriptionally in the cytoplasm through piRNA direct cleavage or, transcriptionally, in the
nucleus via heterochromatin assembly.
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Furthermore, it has been shown that C. albicans contains active RNAi machinery
in vitro and in a heterologous yeast system. CaDcr1 is a non-canonical enzyme that can
generate small RNAs and catalyse the 35S ribosomal RNA [65]. Future studies will establish
the impact of non-coding RNAs in C. albicans biology.
6. Chromatin-Mediated Regulation of the Yeast to Hypha Morphological Switch
Modulation of the yeast to hypha morphological transition relies on a complex in-
terplay of a transcriptional regulator and chromatin modifiers [66,67]. Hyphal growth
can be divided into two different stages: initiation and maintenance. In yeast cells, the
transcriptional repressors Nrg1 and Tup1 inhibit hyphal morphogenesis by blocking the
expression of a subset of filament-specific genes [68,69]. During the initiation stage, Nrg1
protein levels decrease sharply, and the Nrg1-mediated repression is cleared. After that,
during the maintenance phase, Nrg1 protein levels recover rapidly, but Nrg1 binding to
promoters of hypha-specific genes is inhibited [70,71].
Hyphal growth is induced by a broad range of environmental and host factors, includ-
ing serum, nutrient starvation, hypoxia and high CO2 concentration [72,73]. These different
host signals are integrated by redundant sensing pathways that modulate the activity of
transcriptional regulators (such as Chp1, Egf1 and Flo8), resulting in the transcriptional
upregulation of hundreds of genes such as genes encoding for cell wall proteins, adhesins
and secreted aspartyl proteinases (SAP) [74]. Chromatin modifiers are emerging as im-
portant regulators of the yeast-to-hypha transcriptional programme [75–77] (Figure 5A).
For example, the concerted and opposite activities of the NuA4 HAT complex and the
Hda1 HDAC are necessary for the initiation–maintenance transition and for activating the
hyphal-specific transcriptional programme. Upon hyphae induction, the NuA4 complex is
recruited to the promoters of hyphae-specific genes. Dynamic acetylation of histone H4
and the NuA4 components Yng2 have been proposed to be necessary for NuA4-dependent
hypha induction [75,78]. Consequently, deletion of the ESA1 gene, encoding for the cat-
alytic subunit of the NuA4 complex, hinders filamentous growth [75]. The HDAC Hda1
promotes hypha maintenance by deacetylating Yng2, and this modification is critical to
sustaining hyphal maintenance blocking Nrg1 binding to hyphae-specific promoters in
response to serum or nutrient limitation [79]. Importantly, HDA1 is not required for hyphae
maintenance or elongation in hypoxia or the presence of elevated CO2, demonstrating the
complexity of the hyphae regulatory programme [80,81].
Several other histone modifiers are important for the yeast–hyphae switch. For
example, the HAT Gcn5 is a positive regulator of hyphal growth, while the HATs Sas2
and Hat1 are negative regulators of hyphae formation [75,82,83]. The Set3/Hos2 histone
deacetylase complex negatively regulates the yeast-to-hyphae switch by modulating the
kinetics of the filamentous transcriptional programme [76,84]. Furthermore, the catalytic
activity of the HDAC Sir2 modulates hyphae formation, as the number of hyphae is reduced
in a C. albicans strain expressing catalytic inactive Sir2 [77].
It is largely unknown how chromatin modifiers modulate the yeast-to-hyphae switch,
as the critical substrates necessary for this morphological transition have not been iden-
tified yet. Identifying these substrates will be essential to unveil the role of protein post-
translation modifications in filamentous growth as chromatin modifiers modify histones
and non-histones proteins [85,86]. Furthermore, histone crotonylation is emerging as a
crucial post-translation modification regulating C. albicans filamentous growth [87]. As
HATs can catalyse both acetylation and crotonylation, it will be essential to dissect which
modifications are the key regulators of filamentous growth.
Several studies demonstrate that chromatin remodelling controls the yeast-to-hyphae
transition. Indeed, the C. albicans SWI/SNF and RSC chromatin-remodelling complexes
are required for filamentation growth [54,88,89]. However, the molecular mechanism(s)
of the SWI/SNF-mediated regulation of hypha formation is still unclear. Indeed, it has
been shown that, upon hyphal induction, the SWI/SNF catalytic subunit Snf2 binds the
promoters of the hyphae-specific genes HWP1, ALS3 and ECE1 [78]. This observation
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suggests that SWI/SNF directly controls the filamentous transcriptional programme by
chromatin remodelling of hyphae-specific genes. However, genome-wide chromatin profil-
ing of a different SWI/SNF component, Snf6, did not detect any specific interaction with
hyphae-specific genes (including HWP1, ALS3 and ECE1). Furthermore, RNA sequencing
analyses of wild type (WT) and SNF6 deletion strains suggest that SWI/SNF is a general
transcriptional regulator in both yeast and hyphal cells and that SWI/SNF controls filamen-
tation indirectly [88]. Future studies will determine whether Snf2 plays a role in hyphae
formation independently of other SWI/SNF components.
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Although the role of non-coding RNAs in the modulation of hyphal transition is
largely unexplored, genome-wide gene-expression profiling studies have identified several
novel ncRNAs specifically expressed in hyphae-inducing growth conditions [64,90]. It is
still unknown whether these ncRNAs have a function, but it is interesting to note that
some of these non-coding RNAs have expression profiles similar to the expression profile
of hyphae-specific genes. In the future, it will be essential to determine the function of
these ncRNAs.
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7. Chromatin-Mediated Regulation of the Planktonic-Biofilm Transition
C. albicans biofilm consists of a layer of yeast cells overlaid by filamentous hyphal and
pseudo-hyphal cells surrounded by an extracellular matrix formed by polysaccharides and
proteins. The formation of biofilms is a multi-step process consisting of four stages: (1) the
adherence and colonisation of yeast cells to the surface, (2) yeast cell proliferation forming
the basal layer, (3) the growth of hyphae and pseudo-hyphae with the formation of the
extracellular matrix and complex three-dimensional architecture, (4) the dissemination
of progeny biofilm cells to seed new sites [91]. Seven master regulators (Bcr1, Brg1,
Efg1, Flo8, Ndt80, Tec1 and Rob1) are critical for normal biofilm formation in vivo and
in vitro [92,93]. Of these seven regulators, Bcr1, Efg1 and Ndt80 are important modulators
of biofilm formation in non-albicans Candida species that are evolutionarily distant from
C. albicans [94]. The biofilm master regulators are transcriptional regulators controlling
the expression of thousands of genes expressed differentially between yeast and biofilm
cells [95].
An increasing body of evidence suggests that chromatin modifiers and chromatin
remodelling regulate different stages of biofilm formation (Figure 5B). Firstly, a specific
chromatin state, marked by the histone H3 variant H3VCTG (ORF19.6791), acts as a negative
regulator of biofilm formation in planktonic cells [96]. H3VCTG contains three variant amino
acids (Ser31, Thr32 and Thr80) replaced by Val31, Ser32 and Ser80. Val31 and Ser32 are
essential for the variant function. H3VCTG binds promoters of biofilm-related genes in
planktonic cells, but it does not mark these gene promoters in biofilm-inducing growth
conditions. Additionally, H3VCTG mutant strains produce more robust biofilms than WT
cells in vivo and in vitro, suggesting that H3VCTG represses biofilm formation [96]. The
role of H3VCTG in other CTG-clade yeast species is unknown. H3VCTG likely regulates
biological processes distinct from biofilm formation as this histone variant is expressed in
CTG-clade organisms such as Scheffersomyces stipitis and Debaryomyces hansenii that do not
form biofilm under several biofilm-inducing conditions [94,96].
Hyphae formation is important in the biofilm process. Therefore, it is likely that
chromatin modifiers regulating filamentous growth are also required for biofilm matura-
tion. Accordingly, deletion of the HAT GCN5 leads to a strong decrease of adhesion and
a dysregulation of Als1-mediated adhesion, which hints at the role of Gcn5 in biofilm es-
tablishment [84]. Additionally, it has been shown that chromatin-mediated transcriptional
regulation is important for regulating biofilm dispersal. Indeed, the HDAC Set3/Hos2 is
a positive regulator of biofilm dispersal. C. albicans strain deleted for the SET3 gene are
hyper filamentous and have a reduced number of yeast cells leading to a reduced biofilm
dispersal [84].
It is still unknown whether non-coding RNAs regulate biofilm formation. However,
ncRNAs might play an crucial regulatory role in biofilm formation as specific ncRNAs are
differentially expressed in biofilm cells compared to planktonic cells [64].
8. Conclusions
An increasing body of evidence demonstrates that chromatin modifiers and chromatin
remodelers modulate the gene expression programmes associated with the yeast to hyphae
switch and with biofilm formation, two interconnected processes playing important roles
for host adaption and pathogenesis, as well as the white-opaque switch (Figure 6). Despite
the emerging central role of chromatin-mediated regulation in controlling C. albicans biology,
our understanding of these regulatory processes is still in its infancy. This is because we
lack the fundamental knowledge and understanding of how chromatin structures change
in different host hostile environments and whether chromatin modulation differs among
C. albicans clinical isolates. To start filling this gap in knowledge, chromatin profiling of
different C. albicans morphological forms should be performed. Similarly, histone and
non-histone substrates of chromatin modifiers should be identified using biochemical
approaches. In addition, it will be exciting to dissect the role of non-coding RNAs and the
RNAi machinery to C. albicans morphological switches.
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